WC
MBII

Wexford Capital’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Wexford Capital’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,828
Closed -$39K – 259
2021
Q1 		$39K Buy
+18,828
New +$39.1K 0.01% 189

Other funds holding MBII

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Wexford Capital's MBII Position: Q2 2021 in Review

Wexford Capital sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2021, closing a stake of 18,828 shares — an estimated $39K sold.

Wexford Capital first reported a position in MBII in Q1 2021 and held it in 1 quarter. The position peaked at $39K in Q1 2021. 72 funds tracked by Wall St. Rank hold MBII as of Q2 2021.

  • Wexford Capital reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2021 after selling out during the quarter.
  • Wexford Capital sold 18,828 Marrone Bio Innovations, Inc. shares in Q2 2021, an estimated $39K.
  • Wexford Capital first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 1 quarter.
  • Wexford Capital's Marrone Bio Innovations, Inc. position peaked at $39K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2021.

Based on Wexford Capital's 13F filing for Q2 2021, filed 16 Aug 2021.